Highlights from the Barcelona meeting
Biogen Advances Research to Improve Outcomes for Patients with Multiple Sclerosis
News from Biogen
Europe’s only medical cannabis e-learning platform announces the UK as its first learning centre launch
Free and independent platform launched
APPG on ABI launches report on acquired brain injury and neurorehabilitation
APPG on ABI launches report on acquired brain injury and neurorehabilitation
New clinical practice data confirms clinical effectiveness of Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
New clinical practice data on Zebinix® (eslicarbazepine acetate) monotherapy for focal-onset epilepsy in adults
Spinraza® ▼ (nusinersen) Interim Data demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
Spinraza® ▼ (nusinersen) Interim Data from Phase 2 Trial, NURTURE, Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
Why patients should be able to request an Upright Open MRI scan
Industry News from Medserena
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
News from GW Pharma
Phase 3 TOLEDO study results published
News from Britannia Pharmaceuticals